NUDCD1 and cancer: CML66, a novel tumor antigen which played an oncogenic role, was over-expressed in a majority of cancer cell lines and cancers [22], knocking down its expression by CMl66-specific siRNA significantly inhibited proliferation, invasion and metastasis of HeLa cells both in vivo and in vitro experiments [23].